Home › NDC Lookup › RxCUI directory › RxCUI 2678310

Lidocaine 0.05 MG/MG Medicated Patch [Tridacaine] — RxCUI 2678310

RxNorm drug concept · Semantic branded drug
RxCUI 2678310 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2678310
Official nameLidocaine 0.05 MG/MG Medicated Patch [Tridacaine]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTridacaine 5 % Medicated Patch; Tridacaine 0.05 MG/MG Medicated Patch
FDA products mapped3
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves nerve pain from post-herpetic neuralgia, the lingering pain that can follow shingles. It is used in adults. It numbs the pain signals in the skin under the patch.
  • Usually up to 12 hours in a 24-hour period, then 12 hours off. Put it on intact skin over the most painful spot. Do not use more patches than prescribed.
  • No. Heat can increase how much lidocaine gets absorbed. With Ztlido, you can apply a patch after brief heat, but never put a heating pad or electric blanket directly on it.
  • For Ztlido, light exercise and short water exposure, like a 10-minute shower, are okay. Gently pat it dry rather than rubbing. If the edges lift, press them down.
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Lidocaine 0.05 MG/MG Medicated Patch [Tridacaine... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lidocaine 0.05 MG/MG Medicated Patch [Tridacaine] RxCUI 2678310

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lidocaine 6387
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tridacaine 2678306
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lidocaine Medicated Patch 1792943
    • Lidocaine Topical Product 1164666
    • Lidocaine Medicated Patch [Tridacaine] 2678309
    • Tridacaine Topical Product 2678308
    • Medicated Patch 1792831
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Lidocaine 0.05 MG/MG [Tridacaine] SBDC · 2678307
  • Lidocaine Medicated Patch [Tridacaine] SBDF · 2678309
  • Tridacaine Topical Product SBDG · 2678308
  • Tridacaine BN · 2678306

📦 FDA Products & Package NDCs

3 products · 2 package NDCs
2 package NDCs map to RxCUI 2678310 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73352-0835-15 15 PACKET in 1 POUCH (73352-835-15) / 1 g in 1 PACKET (7335... Tridacaine III Trifluent Pharma LLC 2024-06-28
73352-0845-30 30 PACKET in 1 BOX (73352-845-30) / 1 g in 1 PACKET (73352-... Tridacaine XL Trifluent Pharma LLC 2024-09-20
Observed labelers: Trifluent Pharma LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$2.0114
Range $2.0114–$2.0114 · middle 50% $2.0114–$2.0114 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.